WINDTREE THERAPEUTICS INC /DE/ Operating Lease, Liability, Current
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Operating Lease, Liability, Current of $544.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-11-19
- 2025-09-30: Operating Lease, Liability, Current $544.00K.
- 2025-06-30: Operating Lease, Liability, Current $531.00K.
- 2025-03-31: Operating Lease, Liability, Current $519.00K.
- 2024-12-31: Operating Lease, Liability, Current $508.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2025-09-30 | $544.00K 10-Q · filed 2025-11-19 |
| 2025-06-30 | $531.00K 10-Q · filed 2025-08-19 |
| 2025-03-31 | $519.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $508.00K 10-Q · filed 2025-11-19 |
| 2024-09-30 | $468.00K 10-Q · filed 2024-11-26 |
| 2024-06-30 | $457.00K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $446.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $436.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $439.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $399.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $389.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $404.00K 10-K · filed 2024-04-16 |
| 2022-09-30 | $416.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $432.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $472.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $528.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $278.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $336.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $392.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $805.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $605.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $651.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $700.00K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $750.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $781.00K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $656.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $730.00K 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |